Qi lengthening and life-threatening arrhythmias associated with fexofenadine

被引:67
作者
Pinto, YM [1 ]
van Gelder, IC
Heeringa, M
Crijns, HJGM
机构
[1] Univ Groningen Hosp, Thoraxctr, Dept Cardiol, NL-9713 GZ Groningen, Netherlands
[2] Netherlands Pharmacovigilance Fdn, LAREB, Shertogenbosch, Netherlands
关键词
D O I
10.1016/S0140-6736(99)01009-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:980 / 980
页数:1
相关论文
共 4 条
[1]  
EOOSLET RL, 1996, ANN REV PHARM TOXICO, V36, P233
[2]   DRUG-INDUCED TORSADE-DE-POINTES - INCIDENCE, MANAGEMENT AND PREVENTION [J].
FABER, TS ;
ZEHENDER, M ;
JUST, H .
DRUG SAFETY, 1994, 11 (06) :463-476
[3]  
Markham A, 1998, DRUGS, V55, P269, DOI 10.2165/00003495-199855020-00012
[4]   The clinical pharmacology of fexofenadine in children [J].
Simons, FER ;
Bergman, JN ;
Watson, WTA ;
Simons, KJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :1062-1064